Eosinophilia in primary biliary cirrhosis

American Journal of Gastroenterology

Volumn 91, Issue 3, 1996, Pages 516-522

  Yamazaki, Kiyoshi ^a   Nakadate, Ichiro ^a   Suzuki, Kazuyuki ^a   Sato, Shunichi ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELL INFILTRATION; CHOLESTASIS; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; LEUKOCYTE COUNT; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION;

AGED; CHRONIC DISEASE; EOSINOPHILIA; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PREVALENCE; URSODEOXYCHOLIC ACID;

EID: 0029924051     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yamazaki K, Abe S, Nakadate I, et al. Eosinophilia in primary biliary cirrhosis (PBC): A hitherto unrecognized feature. Hepatology 1992; 16:194A (abstract).
2. Vierling JM. Primary biliary cirrhosis. In: Zakim D, Boyer TD, eds. Hepatology, vol 2, 2nd ed. St. Louis: WB Saunders, 1990: 1158-205.
3. Kaplan MM. Primary biliary cirrhosis. N. Engl J Med 1987;316: 521-8.
4. Terasaki S, Nakanuma Y, Yamazaki M, et al. Eosinophilic infiltration of the liver in primary biliary cirrhosis: A morphological study. Hepatology 1993;17:206-12.
5. Martinez OM, Villanueva JC, Gershwin GE, et al. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21:113-9.
6. Kokubun M, Kuroda M, Takagi T, et al. Eosinophilia in PBC patients. Nippon Shokakibyo Gakkai Zasshi 1990;87:1410-6 (in Japanese).
7. Takei M, Yamagami K, Nishinarita S, et al. Polymyositis associated with asymptomatic primary biliary cirrhosis and eosinophilia: An analysis of the mitochondrial antigens by Western blotting. Jpn J Clin Immunol 1991;14:98-104.
8. Yamazaki M, Morimoto H, Wakabayashi T, et al. A patient with asymptomatic primary biliary cirrhosis associated with eosinophilic infiltration and peripheral eosinophilia improved by the administration of ursodeoxycholic acid. Acta Hepatol Jpn 1992;33:348-52 (in Japanese).
9. Wirth HP, Heer P, Bertschinger Ph, et al. Flüchtige Eosinophilie bei primär biliärer Zirrhose. Schweiz Med Wochenschr 1993;123:2278-83.
10. Wirth HP, Meyenberger Ch, Altorfer J, et al. Eosinophilie bei primär biliärer Zirrhose: Regredienz unter Therapie mit Ursodesoxycholsäure. Schweitz Med Wochenschr 1994;124:810-5.
11. Corash L. Automated leukocyte differential analysis by flow cytochemistry. Lab Med 1983;14:503-8.
12. Kaplow L, Orlowski L, Vaznelis ME. Evaluation of the Technicon H6000 hematology system. J Clin Lab Auto 1983;3:167-74.
13. Hoyer JD. Leukocyte differential. Mayo Clin Proc 1993;68:1027-8.
14. Abu-Ghazaleh RI, Kita H, Gleich GJ. Eosinophil activation and function in health and disease. Immunol Ser 1992;57:137-67.
15. Nutman TB, Ottesen EA, Cohen SG. Eosinophilia and eosinophil-related disorders. In: Middleton E Jr, Reed CE, Ellis EF, eds. Allergy: Principles and practice, vol 1, 3rd ed. St. Louis: CV Mosby, 1988: 861-90.
16. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch [A] 1978;379:103-12.
17. Johnson PJ, McFarlane IG. Meeting Report: International autoimmune hepatitis group. Hepatology 1993;18:998-1005.
18. Acland JD, Gould AH. Normal variation in the count of circulating eosinophils in man. J Physiol 1956;133:456-66.
19. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-64.
20. Flier JY, Underhill LH, Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
21. Gittlen SD, Schulman ES, Maddrey WC. Raised histamine concentrations in chronic cholestatic liver disease. Gut 1990;31:96-9.
22. Horny H, Kaiserling E, Campbell M, et al. Liver findings in generalized mastocytosis. A clinicopathologic study. Cancer 1989;63:532-8.
23. Gleich GJ. The eosinophil and bronchial asthma: Current understand ing. J Allergy Clin Immunol 1990;85:422-36.
24. Abe K, Nakadate I, Shimotono K. Ursodeoxycholic acid modulates cytokine production in primary biliary cirrhosis. Gastroenterology 1992;102:A770 (abstract).
25. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, et al. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-400.
26. Neeman A, Kadish U. Marked eosinophilia in a patient with primary sclerosing cholangitis. Am J Med 1987;83:378-9.
27. De Groen PC, Kephart GM, Gleich GJ, et al. The eosinophil as an effector cell of the immune response during hepatic allograft rejection. Hepatology. 1994;20:654-62.
28. Irshad M, Naseer K, Amarnath U, et al. Eosinophilia in total parenteral nutrition (TPN) induced cholestasis in neonates: A marker? Gastroenterology 1992;102:A826 (abstract).
29. Foong A, Scholes JV, Gleich GJ, et al. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome. Hepatology 1991;13:1090-4.
30. Gaia E, Cavalot F, De Giuli P, et al. Colangite sclerosante primitive associata a morbo di Crohn del colon e spiccata eosinofilia: Descrizione di un caso. Minerva Gastroenterol Dietol 1991;37:59-63.
31. Quist RG, Ton-Nu H, Lillienau J, et al. Activation of mast cells by bile acids. Gastroenterology 1991;101:446-56.
32. Tanaka H, Makino I. Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor. Biochem Biophys Res Commun 1992;188: 942-8.